Patents by Inventor Wanmei Li

Wanmei Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11242307
    Abstract: A method for preparing alkynyl 2-halo-2,2-difluoroacetate is disclosed. The method comprises: subjecting a 2-halo-2,2-difluoro acetic acid, an alkynol, and a catalyst to an esterification reaction in a solvent, to obtain alkynyl 2-halo-2,2-difluoroacetate, wherein the catalyst includes one or more of sulfuric acid, phosphoric acid and p-toluenesulfonic acid.
    Type: Grant
    Filed: October 1, 2020
    Date of Patent: February 8, 2022
    Assignees: Hangzhou Transfar Fine Chemical Co., Ltd., Hangzhou Normal University, Zhejiang Transfar Functional New Material Co., Ltd.
    Inventors: Pengfei Zhang, Shengpeng Wang, Wanmei Li, Weiming Xu, Bajin Chen, Xiaojun Wang
  • Publication number: 20220033339
    Abstract: A method for preparing alkynyl 2-halo-2,2-difluoroacetate is disclosed. The method comprises: subjecting a 2-halo-2,2-difluoro acetic acid, an alkynol, and a catalyst to an esterification reaction in a solvent, to obtain alkynyl 2-halo-2,2-difluoroacetate, wherein the catalyst includes one or more of sulfuric acid, phosphoric acid and p-toluenesulfonic acid.
    Type: Application
    Filed: October 1, 2020
    Publication date: February 3, 2022
    Inventors: Pengfei ZHANG, Shengpeng WANG, Wanmei LI, Weiming XU, Bajin CHEN, Xiaojun WANG
  • Patent number: 11161818
    Abstract: A novel quinolone derivative and methods of its preparation are described in which the novel derivative comprises a diphenyl ether substituent on the nitrogen atom at the 1-position of the main quinolone ring. The novel derivative is shown to have antibacterial and anti-tumor cell activity.
    Type: Grant
    Filed: March 24, 2020
    Date of Patent: November 2, 2021
    Assignee: HANGZHOU NORMAL UNIVERSITY
    Inventors: Pengfei Zhang, Wanmei Li, Weiming Xu, Haifeng Wu
  • Patent number: 11161809
    Abstract: The disclosure provides processes for preparing 5-fluoro-2-methyl-1-(4-methylthiobenzylidene)-3-indanacetonitrile and for preparing sulindac, relating to the field of medicine. The former comprises mixing 6-fluoro-2-methyl-1-indanone, cyanoacetic acid, a first organic solvent and an acetic acid-based catalyst to proceed with a first condensation reaction to give a first condensation reaction solution, which contains 5-fluoro-2-methyl-3-indanacetonitrile; and mixing the first condensation reaction solution, per se, with a base, a second organic solvent and 4-(methylthio)benzaldehyde to proceed with a second condensation reaction to give 5-fluoro-2-methyl-1-(4-methylthiobenzylidene)-3-indanacetonitrile. The process is a one-pot process without separation of 5-fluoro-2-methyl-3-indanacetonitrile from the solvent, shortening the synthetic route, simplifying the preparation process and improving the 5-fluoro-2-methyl-1-(4-methylthiobenzylidene)-3-indanacetonitrile yield.
    Type: Grant
    Filed: April 21, 2020
    Date of Patent: November 2, 2021
    Assignees: HANGZHOU NORMAL UNIVERSITY, HANGZHOU LOOP BIOTECH CO., LTD
    Inventors: Weiming Xu, Wanmei Li, Lianzhi Tao, Pengfei Zhang, Hongyun Shen, Dongxiang Feng
  • Publication number: 20210276947
    Abstract: The disclosure provides processes for preparing 5-fluoro-2-methyl-1-(4-methylthiobenzylidene)-3-indanacetonitrile and for preparing sulindac, relating to the field of medicine. The former comprises mixing 6-fluoro-2-methyl-1-indanone, cyanoacetic acid, a first organic solvent and an acetic acid-based catalyst to proceed with a first condensation reaction to give a first condensation reaction solution, which contains 5-fluoro-2-methyl-3-indanacetonitrile; and mixing the first condensation reaction solution, per se, with a base, a second organic solvent and 4-(methylthio)benzaldehyde to proceed with a second condensation reaction to give 5-fluoro-2-methyl-1-(4-methylthiobenzylidene)-3-indanacetonitrile. The process is a one-pot process without separation of 5-fluoro-2-methyl-3-indanacetonitrile from the solvent, shortening the synthetic route, simplifying the preparation process and improving the 5-fluoro-2-methyl-1-(4-methylthiobenzylidene)-3-indanacetonitrile yield.
    Type: Application
    Filed: April 21, 2020
    Publication date: September 9, 2021
    Applicants: HANGZHOU NORMAL UNIVERSITY, HANGZHOU LOOP BIOTECH CO., LTD
    Inventors: Weiming XU, Wanmei LI, Lianzhi TAO, Pengfei ZHANG, Hongyun SHEN, Dongxiang FENG
  • Publication number: 20210198207
    Abstract: A novel quinolone derivative and methods of its preparation are described in which the novel derivative comprises a diphenyl ether substituent on the nitrogen atom at the 1-position of the main quinolone ring. The novel derivative is shown to have antibacterial and anti-tumor cell activity.
    Type: Application
    Filed: March 24, 2020
    Publication date: July 1, 2021
    Inventors: Pengfei ZHANG, Wanmei LI, Weiming XU, Haifeng WU
  • Patent number: 10604466
    Abstract: The present invention provides a method for preparing a resveratrol compound, and belongs to the technical field of organic synthesis. In the present invention, first alkoxy-substituted benzyl halide, alkoxy-substituted benzaldehyde and a metal catalyst are subjected to oxidative addition and reduction elimination reactions to obtain alkoxy-substituted diphenylethanone; and then the alkoxy-substituted diphenylethanone and a metal catalyst are subjected to reduction, trans elimination and selective debenzylation reactions under a hydrogen atmosphere to obtain the resveratrol compound. In the preparation method of the present invention, the hydrogenation reduction, trans elimination and selective debenzylation reactions can be achieved just by a one-pot process, where the reaction directly obtains a trans olefin, thereby avoiding the formation of a isomer; and also the reaction selectively catalyzes debenzylation to eliminate Lewis acids from the source, and has the advantage of a high yield.
    Type: Grant
    Filed: September 5, 2019
    Date of Patent: March 31, 2020
    Assignees: HANGZHOU NORMAL UNIVERSITY, GREAT FOREST BIOMEDICAL LTD.
    Inventors: Weiming Xu, Wanmei Li, Xiaoling Li, Pengfei Zhang, Jinsong Wang, Kejie Chai
  • Patent number: 10125119
    Abstract: The invention discloses a series of resveratrol-derivative fluorescently labeled molecules and a synthesis method thereof. The fluorescently labeled molecules has a molecular formula as shown in formula (I). The synthesis method includes the steps of adding a certain amount of resveratrol derivative and solvent in a reaction vessel, adding a fluorescent marker as shown in formula (III) and a certain amount of alkali, reacting at 20° C.-60° C. for 2-10 hours, and after the reaction is completed, spin-drying the reaction solvent and performing post-processing to obtain the products.
    Type: Grant
    Filed: March 7, 2018
    Date of Patent: November 13, 2018
    Assignee: Hangzhou Normal University
    Inventors: Weiming Xu, Pengfei Zhang, Wanmei Li, Kui Du, Kejie Chai
  • Publication number: 20180273514
    Abstract: The invention discloses a series of resveratrol-derivative fluorescently labeled molecules and a synthesis method thereof. The fluorescently labeled molecules has a molecular formula as shown in formula (I). The synthesis method includes the steps of adding a certain amount of resveratrol derivative and solvent in a reaction vessel, adding a fluorescent marker as shown in formula (III) and a certain amount of alkali, reacting at 20° C.-60° C. for 2-10 hours, and after the reaction is completed, spin-drying the reaction solvent and performing post-processing to obtain the products.
    Type: Application
    Filed: March 7, 2018
    Publication date: September 27, 2018
    Inventors: Weiming Xu, Pengfei Zhang, Wanmei Li, Kui Du, Kejie Chai